Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20101
20111
20141
20151
20161
20181
20191
20203
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Celgene2
AbbVie1
Amgen1
Astex Pharmaceuticals, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GWT-TUD GmbH1
Gilead Sciences1
Pfizer1
Syros Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Anemia4
Leukemia, Myelomonocytic, Chronic4
Anemia, Refractory, with Excess of Blasts3
Leukemia, Myeloid, Acute2
Thalassemia2
Anemia, Diamond-Blackfan1
Anemia, Refractory1
Iron Overload1
Leukemia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.